InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Whitnell Jeffrey A, 董事. Officer active across 1 company, notably Elite Pharmaceuticals INC. In total, 3 disclosures have been recorded. Activity tracked since 30 June 2021. The latest transaction was filed on 22 November 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Jeffrey A. Whitnell is a Director at ELITE PHARMACEUTICALS INC /NV/. In this role, he contributes to the governance of the company and strategic decision-making. Jeffrey brings expertise in the pharmaceutical sector, which is essential for guiding product development and regulatory compliance initiatives. His commitment to innovation and quality is crucial for the long-term success of the company.